C3 and Fabry disease: In this study, we identified a hitherto unrecognized strong complement activation in treatment-naive classic male FD patients with missense or nonsense mutations as evidenced by high serum levels of the anaphylatoxins C3a and C5a, the small cleavage products of C3 and C5.